- Home
- INKT vs DALN Comparison
INKT vs DALN Comparison
Compare INKT & DALN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INKT
- DALN
- Stock Information
- Founded
- INKT 2017
- DALN 1954
- Country
- INKT United States
- DALN United States
- Employees
- INKT N/A
- DALN N/A
- Industry
- INKT Medicinal Chemicals and Botanical Products
- DALN Newspapers/Magazines
- Sector
- INKT Health Care
- DALN Consumer Discretionary
- Exchange
- INKT Nasdaq
- DALN Nasdaq
- Market Cap
- INKT 33.6M
- DALN 38.1M
- IPO Year
- INKT 2021
- DALN 2008
- Fundamental
- Price
- INKT $9.03
- DALN $4.70
- Analyst Decision
- INKT Strong Buy
- DALN
- Analyst Count
- INKT 2
- DALN 0
- Target Price
- INKT $37.50
- DALN N/A
- AVG Volume (30 Days)
- INKT 10.5K
- DALN 50.2K
- Earning Date
- INKT 03-18-2025
- DALN 03-17-2025
- Dividend Yield
- INKT N/A
- DALN N/A
- EPS Growth
- INKT N/A
- DALN N/A
- EPS
- INKT N/A
- DALN 0.02
- Revenue
- INKT N/A
- DALN $125,391,000.00
- Revenue This Year
- INKT N/A
- DALN N/A
- Revenue Next Year
- INKT N/A
- DALN N/A
- P/E Ratio
- INKT N/A
- DALN $249.00
- Revenue Growth
- INKT N/A
- DALN N/A
- 52 Week Low
- INKT $4.56
- DALN $2.98
- 52 Week High
- INKT $19.00
- DALN $7.86
- Technical
- Relative Strength Index (RSI)
- INKT 53.66
- DALN 29.00
- Support Level
- INKT $7.81
- DALN $5.20
- Resistance Level
- INKT $9.23
- DALN $6.31
- Average True Range (ATR)
- INKT 0.85
- DALN 0.50
- MACD
- INKT 0.11
- DALN -0.16
- Stochastic Oscillator
- INKT 68.66
- DALN 0.33
About INKT MiNK Therapeutics Inc.
MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing allogeneic invariant natural killer T-cell therapies to treat cancer and other life-threatening illnesses.
About DALN DallasNews Corporation Series A
DallasNews Corp is a local news and information publishing company in Texas with commercial printing, distribution, and direct mail capabilities, as well as a presence in emerging media and digital marketing.